Clinical trial · Observational
Epidemiological Description of the Kaposi's Disease in France's Southeast
NCT03662828CI-TRIAL-00038605KAPOSI-1unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate the prevalence of the Kaposi's disease in France's southeast on 10 years (from 2007 to 2017)
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Kaposi's Disease | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Prevalence of Kaposi's disease
- timeFrame
- 10 years (2007-2017)
- description
- Diagnosed patients with biopsy, in France's southeast
Secondary outcomes (6)
- measure
- Descriptive analysis of the different form of the Kaposi's disease in the population
- timeFrame
- 10 years (2007-2017)
- description
- Mediterranean form, endemic form, iatrogenic form and epidemic form
- measure
- Descriptive analysis of the population : sociodemographic
- timeFrame
- 10 years (2007-2017)
- description
- sociodemographic characteristics
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosed patients with a Kaposi's disease by biopsy from January 2007 to December 2017 Exclusion Criteria: * Opposition to the use of personal data
References
Publications (0)
Data not yet available
No reference posted for this study.